UK Stocks and Shares and Investment tips
of the Tips: Share Recommendations to week ending 25 5 2007
maker of industrial chains can boast a number of blue chip
customers and despite a rocky period a few years ago now
looks to be making strong progress under its present management.
Buy and hold, suggests the Mail on Sunday.
are the company who secured the contract to collect TV license
fees – stealing it from the Post Office and perhaps
cementing the continuing decline in Post Office numbers.
Its corner shop payment points continue to do well, and
it is now expanding into Romania, a company in which 97
per cent of household bills are paid in cash. Buy and tuck
away, says The Telegraph.
Connection's FCUK slogan has gone from cool to embarrassing
over the last few years – rather like their profits,
which have dropped from £38.1m in 2004 to £4m
last year. A turnaround is in progress, however, and prospects
look reasonably good.
is the time to buy, reckons The Independent.
past year has seen an increase in revenues of 17 per cent
and an increase in operating margins to 3.2 per cent for
the network equipment reseller. Its share price looks set
to continue to rise and the shares look cheap at 13 times
forecast earnings, according to The Telegraph.
merchant Travis Perkins is doing well at the moment, with
this week's trading update revealing a 13.9 per cent increase
in turnover for the first four months of the year, alongside
a 9 per cent increase in like-for-like sales growth.
cashflow and a share price at a discount to its main competitors
means you should keep on buying, says The Times.
it isn't a household name, Enodis manufactures commercial
ovens, refrigerators and other appliances for customers
including McDonalds and Starbucks. Despite a weak dollar,
it has reported a 10 per cent increase in half-year pre-tax
profits, showing its underlying strength. Buy, says The
To Let Go
group Alea has seen its fortunes plummet since its flotation
in 2004, mostly as a result of some costly hurricane claims.
Having failed to secure a fresh batch of funding, the company
has sold off everything possible and has now been offered
a buyout deal by the Fortress Investment Group.
major shareholder is presently refusing to back the deal,
claiming the company's assets are undervalued. The truth,
however, is that there may not ever be a better offer. Sell
while you can, says The Independent.
recently known as SR Pharma, Silence is making significant
progress with technology that can "silence" genes
causing disease. Although early trials are going well, any
long-term owners of Silence shares would do well to lock-in
their profits now – the company's share price has
risen 450 per cent since January 2006. Sell, says The Telegraph.
to Best Buy Tables UK
UK Best Buy Tables
UK Best Buy Tables
No Notice Accounts UK Best Buys
Notice Accounts UK Best Buys
Savings Best Buy Tables
Accounts UK Best Buys
Bank Accounts UK Best Buys
Cash ISAs Best Buys